TAM
Trillium Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,005
| Closed | -$572K | – | 237 |
|
|
2020
Q3 | $572K | Sell |
6,005
-2,743
| -31% | -$261K | 0.02% | 185 |
|
|
2020
Q2 | $978K | Sell |
8,748
-184
| -2% | -$20.6K | 0.04% | 173 |
|
|
2020
Q1 | $650K | Sell |
8,932
-25
| -0.3% | -$1.82K | 0.03% | 179 |
|
|
2019
Q4 | $934K | Sell |
8,957
-494
| -5% | -$51.5K | 0.04% | 184 |
|
|
2019
Q3 | $941K | Buy |
9,451
+96
| +1% | +$9.56K | 0.04% | 187 |
|
|
2019
Q2 | $1.07M | Buy |
9,355
+1,110
| +13% | +$127K | 0.05% | 178 |
|
|
2019
Q1 | $1.04M | Buy |
8,245
+3,859
| +88% | +$485K | 0.05% | 179 |
|
|
2018
Q4 | $595K | Buy |
4,386
+171
| +4% | +$23.2K | 0.03% | 190 |
|
|
2018
Q3 | $1.16M | Sell |
4,215
-155
| -4% | -$42.5K | 0.06% | 182 |
|
|
2018
Q2 | $905K | Sell |
4,370
-24
| -0.5% | -$4.97K | 0.05% | 185 |
|
|
2018
Q1 | $726K | Sell |
4,394
-168
| -4% | -$27.8K | 0.04% | 188 |
|
|
2017
Q4 | $625K | Sell |
4,562
-8
| -0.2% | -$1.1K | 0.03% | 185 |
|
|
2017
Q3 | $622K | Buy |
4,570
+59
| +1% | +$8.03K | 0.04% | 183 |
|
|
2017
Q2 | $548K | Buy |
4,511
+202
| +5% | +$24.5K | 0.03% | 187 |
|
|
2017
Q1 | $456K | Buy |
4,309
+380
| +10% | +$40.2K | 0.03% | 185 |
|
|
2016
Q4 | $399K | Buy |
3,929
+350
| +10% | +$35.5K | 0.03% | 188 |
|
|
2016
Q3 | $365K | Buy |
+3,579
| New | +$365K | 0.02% | 188 |
|